Colin Sweeney

Colin Sweeney is a seasoned professional with extensive experience in corporate development and strategy, currently serving as the Senior Manager at Oruka Therapeutics since June 2025, focusing on innovative biologics for inflammatory conditions. Prior to this role, Colin contributed to the Clinton Health Access Initiative's Global Markets Team, enhancing access to health commodities in low-and middle-income countries. Colin held multiple positions at Ossium Health, including Chief of Staff to the CEO, working on pioneering bone marrow stem cell solutions. Earlier in the career, Colin worked in data analytics and consulting at Clarify Health Solutions and Putnam Associates, advising on strategic health initiatives. Colin holds a Magna Cum Laude degree in Biomedical Engineering from Vanderbilt University, complemented by studies at Universidad Carlos III de Madrid.